DNA鑑定|一生の悩みを2日で解決|国内自社ラボDNA鑑定

[2025 Latest] Is NIPT (Non-Invasive Prenatal Testing) Covered by Insurance? A Complete Guide to Public and Private Insurance and Municipal Support

2025.10.26

Last revised: November 16, 2025

NIPT (Non-Invasive Prenatal Testing) is not covered by public health insurance, municipal subsidies, or private insurance — it is entirely out-of-pocket. This article explains the latest 2025 regulatory status, cost estimates, consultation resources, and an international comparison in detail.

NIPT (Non-Invasive Prenatal Testing) uses a sample of the pregnant mother's blood to assess the risk of fetal chromosomal disorders. Because it can estimate, with high accuracy, the likelihood of conditions such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13) from a simple blood draw, the number of people using this test has risen sharply in recent years [ref:1].

However, many people have questions about the cost, such as "Is NIPT covered by insurance?", "Are there any municipal subsidies?", or "Can private medical insurance cover at least part of the cost?" Even those who are seriously considering the test often hesitate because an out-of-pocket expense of over 100,000 yen can have a significant impact on household finances. Based on the latest information as of October 2025, this article provides a clear and detailed explanation of the current state of insurance systems and municipal support, as well as international comparisons and the outlook for the future.

What is NIPT? Basic knowledge you should know first

What is NIPT? Basic knowledge you should know firstNIPT (Non-Invasive Prenatal Testing) is a screening test that evaluates the risk of fetal chromosomal abnormalities by collecting a small blood sample from a pregnant woman after 10 weeks of pregnancy and analyzing the cell-free fetal DNA it contains. Unlike conventional prenatal tests (amniocentesis or chorionic villus sampling), its greatest advantage is that it is almost non-invasive to the mother [ref:1].

Numerous clinical studies have reported that NIPT's sensitivity (the rate at which it correctly detects a positive) for trisomy 21 exceeds 99%, and its false-positive rate is as low as about 0.1% [ref:6]. However, it is only a "screening test that estimates probability," not a "definitive diagnosis." If the result is positive, a confirmatory test such as amniocentesis or chorionic villus sampling is required to reach a final determination. This point is also important for understanding costs and the insurance system.

Can you use public health insurance (National Health Insurance / Employees' Health Insurance)?

Can you use public health insurance (National Health Insurance / Employees' Health Insurance)?

To put it plainly, NIPT is not covered by National Health Insurance or Employees' Health Insurance. The reason is that this test is classified not as "diagnosis or treatment of a disease" but purely as a "screening test that estimates risk" [ref:1].

Japan's public health insurance system is structured to provide benefits for "medical care aimed at treatment," and preventive care, health checkups, and screening tests are, in principle, excluded from insurance coverage. Since NIPT falls into this category, its cost must be paid entirely out of pocket.

The Ministry of Health, Labour and Welfare's published "Guidelines on Information Provision and Facility (Medical Institution/Testing Laboratory) Certification for Prenatal Genetic Testing Using Maternal Blood (NIPT), etc." also contains no statement indicating insurance coverage [ref:1]. While these guidelines discuss the implementation framework for NIPT and the importance of genetic counseling, they assume that the test is a self-pay medical service in terms of cost.

Why isn't NIPT covered by insurance? The institutional background

Why isn't NIPT covered by insurance? The institutional backgroundLet's dig a little deeper into why NIPT is not covered by insurance. Japan's public health insurance system generally applies the following three criteria when determining insurance coverage.

  1. The medical procedure must directly aim at "diagnosis, treatment, or prevention of a disease"
  2. There must be sufficient evidence regarding efficacy, safety, and cost-effectiveness
  3. Approval by the Minister of Health, Labour and Welfare following deliberation by the Central Social Insurance Medical Council (Chuikyo)

NIPT estimates the "risk" of fetal chromosomal abnormalities; it does not diagnose or treat a disease in the mother. Furthermore, because it is a screening test, even a positive result does not constitute a definitive diagnosis, and additional testing is required. This positioning as "a screening that does not lead to a definitive diagnosis" is one of the hurdles to insurance coverage [ref:3].

In addition, prenatal testing involves ethical debate. Concerns that it "could lead to the selection of life based on the presence or absence of a disability" mean the government has taken a cautious stance toward actively recommending the test, which is thought to be another factor behind the lack of insurance coverage [ref:4].

How much does NIPT cost? Price ranges by facility

NIPT costs vary by facility, but generally range from around 100,000 to 200,000 yen [ref:3]. The main factors behind the price differences are summarized below.

  • The scope of test items (whether it covers only the three basic trisomies, or also sex chromosome abnormalities and microdeletions)
  • Whether genetic counseling is provided, and its content
  • Whether the facility is certified or non-certified
  • Whether there is a subsidy for confirmatory testing costs in the event of a positive result

At certified facilities (those certified by the Japanese Association of Medical Sciences), genetic counseling is mandatory both before and after the test, which tends to make the cost somewhat higher — but this comes with the benefit of receiving a thorough explanation of the test's significance and risks. Non-certified facilities, on the other hand, may offer relatively lower prices, but there have been reports of inadequate counseling systems and follow-up in the event of a positive result [ref:4].

Note that NIPT costs may potentially qualify for a medical expense deduction. For tax purposes, the medical expense deduction applies to "payments made in exchange for medical examination or treatment," and whether prenatal testing falls under "medical examination" is determined on a case-by-case basis, so it is recommended that you consult the tax office or a tax accountant when filing your tax return.

Is there prefectural support?

Regarding the question, "Is there a subsidy program from local governments?" — as of October 2025, none of Japan's 47 prefectures subsidize the cost of the NIPT test itself. There is currently no cost-subsidy program specifically for prenatal testing at either the national or municipal level.

However, local governments do provide consultation support and information regarding prenatal testing, including NIPT. Each prefecture's "Center for Consultation on Sexuality and Health" (formerly the "Women's Health Support Center") and public health centers have established consultation windows where people can discuss anxieties or ethical concerns before testing, as well as how to respond after the test [ref:2].

The "National List of Consultation Desks" provided by the Ministry of Health, Labour and Welfare and the Children and Families Agency allows you to check contact information by prefecture.

List of Consultation Centers Nationwide (cfa.go.jp)

In this way, municipal support focuses not on "financial assistance" but on "information support" and "psychological support." At these consultation desks, genetic counselors, midwives, and public health nurses often respond to inquiries, playing an important role in helping people decide whether to undergo testing. If you have concerns or questions before testing, it's recommended that you first make use of these free consultation services.

How private medical insurance handles it

There are very few cases where private medical insurance (life insurance or medical insurance) provides benefits for NIPT. Most insurance products are designed to cover medical expenses related to "treatment" or "a definitively diagnosed disease," and procedures performed purely for testing purposes are excluded [ref:5].

For example, while benefits may be provided for hospitalization, surgery, or advanced medical treatment, "genetic testing" and "prenatal diagnosis" are often excluded. In addition, since NIPT is a test performed on the fetus, it is not considered treatment for a disease in the mother.

Some overseas insurance plans do offer partial to full reimbursement of NIPT costs under certain conditions, so if you are considering coverage through a foreign insurance plan, you should check the following with the insurer you have or are considering:

  1. Whether prenatal diagnosis or genetic testing is included as a covered benefit
  2. Whether "tests not performed for diagnostic purposes" are an excluded category
  3. Whether there are past payout examples (cases where benefits were actually paid)

At present, no private medical insurance product in Japan has been publicly confirmed to clearly cover NIPT [ref:5]. However, since insurance products are revised year by year, it is not impossible that a "prenatal testing rider" or similar option could appear in the future. When considering the test, reviewing the terms and conditions of your current policy is one option worth taking.

Is NIPT covered by insurance overseas? The situation in various countries

While NIPT is a self-pay test in Japan, some countries overseas have made progress in applying public insurance or subsidy programs to it. Let's look at some representative examples.

United Kingdom (NHS): The National Health Service (NHS) provides NIPT free of charge as an additional test for pregnant women who are assessed as high-risk by conventional screening tests. It was trialed starting in 2018 and has since been rolled out nationwide in stages [ref:7].

Netherlands: Since 2017, the Netherlands has incorporated NIPT into a publicly funded screening program, allowing pregnant women who wish to undergo the test to do so for a small out-of-pocket fee.

Belgium: Since 2017, NIPT has been covered by public health insurance in Belgium, allowing all pregnant women to undergo the test for a small out-of-pocket fee.

United States: In the U.S., where private insurance is the norm, coverage varies by insurer. There are cases where NIPT costs are covered when certain risk factors are present, such as advanced maternal age (35 or older) or a chromosomal abnormality in a previous pregnancy.

In this way, Western countries have widely recognized the usefulness of NIPT, and momentum is building to incorporate it into public support frameworks. Similar discussions may progress in Japan in the future as well.

Possibility of future regulatory changes

In 2022, the Japanese Association of Medical Sciences newly established a "prenatal testing certification system," clarifying the standards for facilities performing NIPT. In addition, the Children and Families Agency is strengthening the framework for providing information on prenatal testing, and national involvement is gradually increasing [ref:2].

At present, no concrete public discussion has taken place regarding insurance coverage for NIPT, but the following social changes could become factors driving future regulatory reform.

  • Growing demand for NIPT due to the rise in later marriages and older maternal age at childbirth
  • Advances in testing technology and declining test costs
  • The spread of insurance coverage in Western countries and the international trend
  • Maturing genetic counseling frameworks and ethical discussions
  • The healthcare-economic benefit of reducing unnecessary invasive tests (such as amniocentesis)

In particular, if the spread of NIPT reduces the number of unnecessary amniocentesis procedures, this could lower the risk of miscarriage while also potentially reducing overall healthcare costs. From this perspective, it is quite possible that discussions about insurance coverage or partial public funding will progress over the medium to long term.

What you can do to reduce the financial burden

Currently, NIPT is entirely self-funded, but there are still things you can do to reduce the financial burden somewhat.

  • Use the medical expense deduction: When filing for the medical expense deduction on your tax return, NIPT costs may be eligible. Be sure to keep your receipts
  • Compare prices across facilities: Since pricing structures differ between certified and non-certified facilities, compare the costs and services offered by multiple facilities
  • Choose your test items carefully: Some facilities offer lower costs if you only need the basic three-trisomy test. Discussing with your doctor which test items are truly necessary is one way to narrow things down
  • Subsidies for confirmatory testing after a positive result: Some facilities offer plans that cover the cost of amniocentesis if the NIPT result is positive. It's important to think in terms of total cost
  • Use free consultation services: By using your local government's consultation desk, you can get an expert opinion on whether testing is necessary at no cost, which can also help you avoid unnecessary spending

Summary

As maternal age at pregnancy rises and the technology becomes more widespread, NIPT is expanding rapidly, but in Japan's institutional framework it remains positioned as a "self-pay test." In Western countries, public insurance coverage is advancing in some nations, and discussions about regulatory reform may take place in Japan in the future as well, but the current situation is as follows.

  • Public health insurance (National Health Insurance / Employees' Health Insurance): Not covered, entirely self-pay
  • Prefectural subsidies: None (though consultation support is available)
  • Private medical insurance: In principle, not covered
  • Cost estimate: Around 100,000 to 200,000 yen

When considering the test, it's important to thoroughly discuss not just the cost, but also the significance and risks of the test and your readiness to accept the results, with your doctor and a genetic counselor. We also recommend making use of free consultation services offered by local governments to make an informed decision based on accurate information [ref:2]. In terms of cost, please consider the options available to you, such as using the medical expense deduction and comparing multiple facilities.

/Find out your unborn baby's genetic disease risk\

Frequently Asked Questions

Q1. Isn't NIPT covered under the 30% co-pay of health insurance?

A. No, NIPT is not covered by public health insurance. Because NIPT is "a screening test that estimates risk" and does not fall under medical care directly aimed at "diagnosing or treating a disease," it is not covered by either National Health Insurance or Employees' Health Insurance, and the full cost must be paid out of pocket [ref:1].

Q2. Is the cost of NIPT eligible for a medical expense deduction?

A. It may be eligible for the medical expense deduction. Since tax treatment is determined on a case-by-case basis, we recommend checking with the tax office or a tax accountant when filing your tax return. In any case, be sure to keep your test receipts.

Q3. Is there a cost subsidy for NIPT from local governments?

A. As of October 2025, none of Japan's 47 prefectures have a program that subsidizes the cost of the NIPT test itself. However, each local government's consultation center has established a free consultation service for anxieties and concerns before and after testing, so information support and psychological support are available [ref:2].

Q4. Are there countries overseas where NIPT is covered by insurance?

A. Yes, in the United Kingdom (NHS), the Netherlands, and Belgium, NIPT is provided as part of public insurance or publicly funded programs [ref:7]. In the United States, some private insurers cover the cost under certain conditions, such as advanced maternal age. It's possible that similar systems may be considered in Japan in the future as well.

Q5. Can private life insurance or medical insurance cover the cost of NIPT?

A. At present, no private medical insurance product in Japan has been confirmed to clearly cover NIPT. Most insurance products are designed to cover costs related to "treatment" or "a definitively diagnosed disease," and screening tests are almost always excluded [ref:5]. However, since insurance products are updated over time, we recommend checking the terms of your current policy again.

Q6. What is the typical cost range for the NIPT test?

A. It varies depending on the facility and the scope of the test items, but generally ranges from about 100,000 to 200,000 yen. A basic test covering only the three trisomies tends to be relatively inexpensive, while an expanded test that includes sex chromosomes or microdeletions tends to cost more [ref:3]. Whether genetic counseling is provided and whether there is a subsidy for confirmatory testing in the event of a positive result also affect the total cost.

Reassuring Support from the seeDNA Institute of Genetic Medicine

The seeDNA Institute of Genetic Medicine is a trusted specialist institution for DNA testing and genetic testing that holds the international quality standard ISO 9001 certification and the Privacy Mark for privacy protection.
If you have concerns about family or parent-child biological relationships, or a partner's infidelity, our DNA testing experts are here to support you so you can feel at ease — please feel free to contact us.

[Free Consultation with Specialist Staff]

Customer support at the seeDNA Institute of Genetic Medicine

If you have any questions,
please feel free to contact our toll-free number.

/Open every day, including weekends\
Business hours: Monday-Sunday 9:00 AM-6:00 PM
(excluding holidays)

Dr. Yoshinori Tomikane, M.D., Ph.D., seeDNA Institute of Genetic MedicineAuthor

Yoshinori Tomikane, M.D., Ph.D.

Completed his master's and doctoral studies in Biosystems and Molecular Medicine Science at the University of Tsukuba
In 2017, developed Japan's first prenatal DNA testing(Patent 7331325) using trace-DNA analysis technology(Patent 7121440)

[References]